JUN 05, 2019 10:25 AM PDT

Anti-Diabetic Drug Reduces Anxiety-Like Symptoms

WRITTEN BY: Nouran Amin

In a study published in the Journal of Neuroscience, an antidiabetic drug called metformin was found to alleviate anxiety-like behavioral symptoms in male mice.

The paper ‘Metformin promotes anxiolytic and antidepressant-like responses in insulin-resistant mice by decreasing circulating branched-chain amino acids’ found that beyond its clinical relevance in diabetes—metformin increased serotonin availability in the brain. It’s important to note that metformin is a medication often prescribed to treat high blood sugar by reducing glucose production in the liver and increasing insulin sensitivity.

The present study demonstrated that the insulin-sensitizing drug metformin administered to mice on a high fat diet has reduced the levels of amino acids that impair tryptophan entry into the brain. Tryptophan is a precursor molecule that is converted to serotonin.

The antidepressant-like effects of the medication was accompanied by an improved neurotransmission in the hippocampus. Similar effects were achieved upon the reduction of the so-called branched chained amino acids in the diet.

Individuals with diabetes are often prone to mood disorders most commonly depression. Despite the mechanisms underlying the relationship remain unknown, some studies suggest that the precursor to diabetes –insulin resistance and its connection to depression may be pinpointed to a strong culprit, the neurotransmitter serotonin.

The increase of serotonin along with the reduction in anxiety-like behaviors are findings that can implicate treatments for patients with both metabolic and mental disorders.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 04, 2019
Cannabis Sciences
DEC 04, 2019
Is Cannabis Helping America Sleep?
Researchers find cannabis is being used as a sleep-aid in Colorado. Many Americans struggle with sleep disturbances -- some estimates put the percentage at...
DEC 09, 2019
Drug Discovery & Development
DEC 09, 2019
MagLev: Telling Drugs Apart
Likely, a suspicious powder will be composed of illicit drugs but nothing is certain until confirmation. To do so, analysis must be quick and efficient and...
DEC 18, 2019
Drug Discovery & Development
DEC 18, 2019
Stroke Drug Enhances Stem Cell Therapies for Spinal Cord Injuries
Using rat models of spinal cord injuries, Yasuhiro Shiga, MD, PhD, thought treating them with stem cell therapy would point to nowhere but the nature of re...
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
Acid-Reflux Drugs May Negatively Impact Breast Cancer Survivors
Many of us have taken some form of an acid-reflux drug—especially after a meal that causes discomfort. However, now researchers are indicating that s...
FEB 06, 2020
Drug Discovery & Development
FEB 06, 2020
China Begins Trials for Antiviral Drug to Tackle Coronavirus
So far, coronavirus has infected over 31,493 people globally, and has killed 638. Although 1,563 people have reportedly recovered, due to its fast-spreadin...
FEB 08, 2020
Cancer
FEB 08, 2020
Magic mushrooms help cancer patients' depression
A follow-up to a study originally published in the Journal of Psychopharmacology in 2016 reports the long-term benefits of a one-time, single-dose tre...
Loading Comments...